Zurcher Kantonalbank (Zurich Cantonalbank) Nektar Therapeutics Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$30.1 Billion
Q2 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$2.03 - $4.28 $17,947 - $37,839	8,841 Added 35.48%	33,757 $76,000
Q1 2022 Apr 21, 2022	SELL	$4.16 - $13.72 $15,046 - $49,625	-3,617 Reduced 12.68%	24,916 $134,000
Q4 2021 Feb 01, 2022	BUY	$10.83 - $18.41 $107,162 - $182,166	9,895 Added 53.09%	28,533 $385,000
Q1 2021 May 03, 2021	SELL	$16.56 - $25.46 $56,618 - $87,047	-3,419 Reduced 15.5%	18,638 $373,000
Q4 2020 Jan 28, 2021	BUY	$15.77 - $19.03 $34,347 - $41,447	2,178 Added 10.96%	22,057 $375,000
Q2 2020 Jul 28, 2020	BUY	$16.86 - $23.44 $66,310 - $92,189	3,933 Added 24.66%	19,879 $460,000
Q1 2020 May 06, 2020	BUY	$14.47 - $27.96 $49,183 - $95,036	3,399 Added 27.09%	15,946 $285,000
Q4 2019 Jan 21, 2020	SELL	$15.87 - $23.12 $399,543 - $582,069	-25,176 Reduced 66.74%	12,547 $271,000
Q2 2019 Jul 30, 2019	SELL	$31.0 - $36.3 $34,813 - $40,764	-1,123 Reduced 2.89%	37,723 $1.34 Million
Q1 2019 Apr 29, 2019	BUY	$31.58 - $46.35 $73,549 - $107,949	2,329 Added 6.38%	38,846 $1.31 Million
Q4 2018 Jan 25, 2019	BUY	$30.43 - $56.65 $45,401 - $84,521	1,492 Added 4.26%	36,517 $1.2 Million
Q2 2018 Aug 06, 2018	BUY	$46.25 - $104.45 $1.12 Million - $2.53 Million	24,243 Added 224.85%	35,025 $1.71 Million
Q1 2018 May 03, 2018	BUY	$57.4 - $108.44 $103,320 - $195,192	1,800 Added 20.04%	10,782 $1.15 Million
Q4 2017 Jan 31, 2018	BUY	$23.02 - $60.5 $77,784 - $204,429	3,379 Added 60.31%	8,982 $536,000
Q3 2017 Nov 08, 2017	BUY	$17.79 - $24.0 $99,677 - $134,472	5,603	5,603 $134,000

Others Institutions Holding NKTR

# of Institutions

140

Shares Held

135M

Call Options Held

32.8K

Put Options Held

55.5K

Deep Track Capital, LP Greenwich, CT

17.9M
Shares

$23.2 Million
0.73% of portfolio
Black Rock Inc. New York, NY

15.2M
Shares

$19.7 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

13M
Shares

$16.9 Million
0.0% of portfolio
Samlyn Capital, LLC New York, NY

9.46M
Shares

$12.3 Million
0.21% of portfolio
Eventide Asset Management, LLC Boston, MA

7.53M
Shares

$9.79 Million
0.16% of portfolio

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account